Landscapes / Companies
Grünenthal GmbH not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 5 in all
Trials
3 active
12 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Sep 2027Phase 2 trial completes | |||
| Next date | Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Acute Pain, Bunionectomy | ||||
| Open drug page | |||||
— |
Phase 2 | 4 Jan 2030Phase 2 trial completes | |||
| Next date | 4 Jan 2030 · Phase 2 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy (DMD) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Treatment of Pain | ||||
| Open drug page | |||||
About
- No active trial
- RTX-GRT7039, Versatis
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021